Results for
"[search-keyword]"
Sponsor content
9 result(s) found, displaying 1 to 9
- AusPAR: OnpattroAustralian Public Assessment Report (AusPAR)AusPAR for Onpattro (patisiran) for treatment of hATTR amyloidosis in adult patients with stage 1 or stage 2 polyneuropathy.
- GIVLAARI Alnylam Australia Pty LtdJan-2023Prescription medicine evaluationActive ingredient: givosiran sodium.
- OnpattroPrescription medicine decision summaryOnpattro (patisiran) is approved to treat polyneuropathy.
- ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial (380813)ARTGAustralian Register of Therapeutic Goods (ARTG) information for ONPATTRO patisiran 10 mg/5 mL concentrated injection for infusion vial.
- ONPATTRO (Alnylam Australia Pty Ltd)Prescription medicine registrationActive ingredients: patisiran.